BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17602568)

  • 1. Prediction of drug degradants using DELPHI: an expert system for focusing knowledge.
    Pole DL; Ando HY; Murphy ST
    Mol Pharm; 2007; 4(4):539-49. PubMed ID: 17602568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of MS/MS data. 1. A focus on pharmaceuticals containing carboxylic acids.
    Bandu ML; Watkins KR; Bretthauer ML; Moore CA; Desaire H
    Anal Chem; 2004 Mar; 76(6):1746-53. PubMed ID: 15018578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico prediction of pharmaceutical degradation pathways: a benchmarking study.
    Kleinman MH; Baertschi SW; Alsante KM; Reid DL; Mowery MD; Shimanovich R; Foti C; Smith WK; Reynolds DW; Nefliu M; Ott MA
    Mol Pharm; 2014 Nov; 11(11):4179-88. PubMed ID: 25364862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated aging: prediction of chemical stability of pharmaceuticals.
    Waterman KC; Adami RC
    Int J Pharm; 2005 Apr; 293(1-2):101-25. PubMed ID: 15778049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceuticals in the environment: good practice in predicting acute ecotoxicological effects.
    Madden JC; Enoch SJ; Hewitt M; Cronin MT
    Toxicol Lett; 2009 Mar; 185(2):85-101. PubMed ID: 19118609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculated carbon-hydrogen bond dissociation enthalpies for predicting oxidative susceptibility of drug substance molecules.
    Sharp TR
    Int J Pharm; 2011 Oct; 418(2):304-17. PubMed ID: 21575693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of degradant profiling in active pharmaceutical ingredients and drug products.
    Alsante KM; Ando A; Brown R; Ensing J; Hatajik TD; Kong W; Tsuda Y
    Adv Drug Deliv Rev; 2007 Jan; 59(1):29-37. PubMed ID: 17187892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-the-fly selection of a training set for aqueous solubility prediction.
    Zhang H; Ando HY; Chen L; Lee PH
    Mol Pharm; 2007; 4(4):489-97. PubMed ID: 17628076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive strategy for the rapid structure elucidation of drug degradants.
    Rourick RA; Volk KJ; Klohr SE; Spears T; Kerns EH; Lee MS
    J Pharm Biomed Anal; 1996 Sep; 14(12):1743-52. PubMed ID: 8887722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive Workflow: novel software architecture for automating drug design.
    Cartmell J; Krstajic D; Leahy DE
    Curr Opin Drug Discov Devel; 2007 May; 10(3):347-52. PubMed ID: 17554862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-principle, structure-based prediction of hepatic metabolic clearance values in human.
    Li H; Sun J; Sui X; Liu J; Yan Z; Liu X; Sun Y; He Z
    Eur J Med Chem; 2009 Apr; 44(4):1600-6. PubMed ID: 18768239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful prediction of a model pharmaceutical in the fifth blind test of crystal structure prediction.
    Kazantsev AV; Karamertzanis PG; Adjiman CS; Pantelides CC; Price SL; Galek PT; Day GM; Cruz-Cabeza AJ
    Int J Pharm; 2011 Oct; 418(2):168-78. PubMed ID: 21497184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico prediction of ionization constants of drugs.
    Lee PH; Ayyampalayam SN; Carreira LA; Shalaeva M; Bhattachar S; Coselmon R; Poole S; Gifford E; Lombardo F
    Mol Pharm; 2007; 4(4):498-512. PubMed ID: 17629304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive oral drug absorption can be predicted more reliably by experimental than computational models--fact or myth.
    Linnankoski J; Ranta VP; Yliperttula M; Urtti A
    Eur J Pharm Sci; 2008 Jul; 34(2-3):129-39. PubMed ID: 18455374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting biotransformation potential from molecular structure.
    Borodina Y; Sadym A; Filimonov D; Blinova V; Dmitriev A; Poroikov V
    J Chem Inf Comput Sci; 2003; 43(5):1636-46. PubMed ID: 14502498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
    Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
    Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prediction of ADMET properties using structure information representations.
    Kier LB; Hall LH
    Chem Biodivers; 2005 Nov; 2(11):1428-37. PubMed ID: 17191944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.